| Website | glidepharma.com |
| Category | BioTech |
| Phone | +44 (0) 8700 853700 |
| enquiries@glideph... | |
| Employees |
| TOTAL | $25.5M |
| FUNDING TOTAL | $25.5M |
| Series D, 3/10 Hygea VCT Oxford Technology Management | $4.3M |
| Private Equity, 2/13 Invesco Perpetual | £14M |
Glide Pharma is a specialty pharmaceutical company developing products for easy, safe and convenient delivery of biological medicines such as proteins and vaccines based on its proprietary Glide SDI® - the Solid Dose Injector. By being much less invasive than traditional injection methods, Glide improves the treatment experience of both patients and carers and, by allowing the injection of solid formulations, opens up a wide range of therapeutic options for new and existing treatments. The Glide SDI® is simple, clean and easy to use, even at home, bringing injection technology into the 21st century.
